Health
CEBINA reports positive findings on the potency of azelastine, a widely used anti-histamine, as anti-COVID-19 approach – PRNewswire
/PRNewswire/ — CEBINA GmbH, an Austrian biotech company, today announces further positive results in its collaborative COVID-19 drug repurposing project,…
VIENNA, Sept. 17, 2020 /PRNewswire/ — CEBINA GmbH, an Austrian biotech company, today announces further positive results in its collaborative COVID-19 drug repurposing project, demonstrating that a common allergy nasal spray medication containing azelastine has potent efficacy against SARS-CoV-2 in a human 3D nasal tissue model.
Azelastine, a generic anti-histamine medication, has previously been identified as a potential anti-COVID-19 drug by CEBINA in collaboration with Professor Robert Konr…
-
General11 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News20 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News11 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General18 hours agoCrowe toasts talkback titan for platforming ‘voiceless’